Lilly Soars to $1,500 Target as McDonald's Gets Slapped

Analysts are making bold calls today. The moves span pharma, tech, and fast food — with some notable target price swings.

Eli Lilly Gets a Mega-Raise

JP Morgan's Chris Schott lifted his price target on LLY to $1,500, up from $1,400. That's a $100 jump on a stock with a $1 trillion market cap. Schott keeps a Buy rating. The new target implies further upside from current levels. Lilly's short interest sits at just 0.8% of free float — bears are not fighting this trend.

Lumentum Targets Climb Higher

LITE got a consensus target price increase to $1,157, up from $1,149. All 22 covering analysts hold a Buy. The photonics maker has become a data-centre AI infrastructure play. Short interest is light at 8% of free float.

McDonald's Hit With Sell and Lower Target

Melius Research's Jacob Aiken Phillips cut his target on MCD to $230 from $250. The firm keeps a Sell rating. The $20 target cut is one of the sharpest today. McDonald's faces ongoing pressure from consumer trade-down trends and rising labour costs.

COIN Gets Fresh Buy

Keefe, Bruyette & Woods initiated COIN with a Buy at $237. The crypto exchange has recovered sharply in 2026. Eleven analysts now hold Buy ratings on the stock.

CRH Target Trimmed

CRH saw its consensus target edge down slightly to $133.17. The building materials giant holds 22 Buy ratings. The small move reflects analysts fine-tuning rather than any fundamental shift.